Is there a "mucosa-sparing" benefit of IMRT for head-and-neck cancer?

International Journal of Radiation Oncology Biology Physics

Volumn 66, Issue 3, 2006, Pages 931-938

  Sanguineti, Giuseppe ^a   Endres, Eugene J ^b   Gunn, Brandon G ^a   Parker, Brent ^b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Acute mucositis; Altered fractionation; IMRT

Indexed keywords

BIOMEDICAL ENGINEERING; DRUG DOSAGE; TUMORS;

ACUTE MUCOSITIS; ALTERED FRACTIONATION; INTENSITY-MODULATED RADIATION THERAPY (IMRT);

RADIOTHERAPY;

ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MUCOSA; OROPHARYNX CANCER; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION;

CARCINOMA, SQUAMOUS CELL; HUMANS; MOUTH MUCOSA; OROPHARYNGEAL NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY, INTENSITY-MODULATED; RESPIRATORY MUCOSA;

EID: 33748935721     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.05.060     Document Type: Article

References (31)

1. Skarsgard D.P., Groome P.A., Mackillop W.J., et al. Cancers of the upper aerodigestive tract in Ontario, Canada, and the United States. Cancer 88 (2000) 1728-1738
2. Carvalho A.L., Nishimoto I.N., Califano J.A., et al. Trends in incidence and prognosis for head and neck cancer in the United States: A site-specific analysis of the SEER database. Int J Cancer 114 (2005) 806-816
3. Fu K.K., Pajak T.F., Trotti A., et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003. Int J Radiat Oncol Biol Phys 48 (2000) 7-16
4. Horiot J.C., Le Fur R., N'Guyen T., et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: Final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 25 (1992) 231-241
5. Bourhis J., and Pignon J.P. Meta-analyses in head and neck squamous cell carcinoma. What is the role of chemotherapy?. Hematol Oncol Clin North Am 13 (1999) 769-775
6. Overgaard J., Hansen H.S., Specht L., et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 362 (2003) 933-940
7. Trotti A., Bellm L.A., Epstein J.B., et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: A systematic literature review. Radiother Oncol 66 (2003) 253-262
8. Skladowski K., Law M.G., Maciejewski B., et al. Planned and unplanned gaps in radiotherapy: The importance of gap position and gap duration. Radiother Oncol 30 (1994) 109-120
9. Robertson A.G., Robertson C., Perone C., et al. Effect of gap length and position on results of treatment of cancer of the larynx in Scotland by radiotherapy: A linear quadratic analysis. Radiother Oncol 48 (1998) 165-173
10. Sutherland S.E., and Browman G.P. Prophylaxis of oral mucositis in irradiated head-and-neck cancer patients: A proposed classification scheme of interventions and meta-analysis of randomized controlled trials. Int J Radiat Oncol Biol Phys 49 (2001) 917-930
11. Vera-Llonch M., Oster G., Hagiwara M., et al. Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer 106 (2006) 329-336
12. Sanguineti G., Sosa M., Culp L., et al. Is it feasible to spare part of the mucosa with IMRT and does it matter. Int J Radiat Oncol Biol Phys 60 (2004) S517-S518
13. RTOG protocol 0022. Phase I/II study of conformal and intensity modulated irradiation for oropharyngeal cancer. http://www.rtog.org.members/protocols/h0022.pdf.
14. Sanguineti G., Culp L.R., Endres E.J., et al. Are neck nodal volumes drawn on CT slices covered by standard three-field technique?. Int J Radiat Oncol Biol Phys 59 (2004) 725-742
15. Ang K.K., and Garden A.S. Radiotherapy for head and neck cancers. 2nd ed. (2002), Lippincott Williams and Wilkins Publishers, Philadelphia
16. Aref A., Gross M., Fontanesi J., et al. Adequate irradiation of the internal jugular lymph node chain: Technical considerations. Int J Radiat Oncol Biol Phys 37 (1997) 269-273
17. Garden A.S., Asper J.A., Morrison W.H., et al. Is concurrent chemoradiation the treatment of choice for all patients with Stage III or IV head and neck carcinoma?. Cancer 100 (2004) 1171-1178
18. Dabaja B., Salehpour M.R., Rosen I., et al. Intensity-modulated radiation therapy (IMRT) of cancers of the head and neck: comparison of split-field and whole-field techniques. Int J Radiat Oncol Biol Phys 63 (2005) 1000-1005
19. Wheldon T.E., Deehan C., Wheldon E.G., et al. The linear-quadratic transformation of dose-volume histograms in fractionated radiotherapy. Radiother Oncol 46 (1998) 285-295
20. Bentzen S.M., Saunders M.I., Dische S., et al. Radiotherapy-related early morbidity in head and neck cancer: Quantitative clinical radiobiology as deduced from the CHART trial. Radiother Oncol 60 (2001) 123-135
21. Mohan R., Wu Q., Manning M., et al. Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers. Int J Radiat Oncol Biol Phys 46 (2000) 619-630
22. Fletcher G.H. Textbook of radiotherapy. 3rd ed. (1980), Lea & Febiger Publishers, Philadelphia
23. Garden A.S., Morrison W.H., Rosenthal D.I., et al. Target coverage for head and neck cancers treated with IMRT: Review of clinical experiences. Semin Radiat Oncol 14 (2004) 103-109
24. Lee N, Puri DR, Blanco AI, Chao KS. Intensity-modulated radiation therapy in head and neck cancers: An update. Head Neck 2005; epub [ahead of print].
25. Intensity-modulated radiotherapy: current status and issues of interest. Int J Radiat Oncol Biol Phys 51 (2001) 880-914
26. Marcial V.A., Pajak T.F., Rotman M., et al. "Compensated" split-course versus continuous radiation therapy of carcinoma of the tonsillar fossa. Final results of a prospective randomized clinical trial of the Radiation Therapy Oncology Group. Am J Clin Oncol 16 (1993) 389-396
27. Fowler J.F., Harari P.M., Leborgne F., et al. Acute radiation reactions in oral and pharyngeal mucosa: Tolerable levels in altered fractionation schedules. Radiother Oncol 69 (2003) 161-168
28. Ang K.K., Peters L.J., Weber R.S., et al. Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx. Int J Radiat Oncol Biol Phys 19 (1990) 1339-1345
29. Shogan G., Bhatnagar A., Heron D., et al. Dosimetric correlation of oral cavity dose with acute mucositis in patients treated with intensity modulated radiation therapy (IMRT) and chemotherapy. Int J Radiat Oncol Biol Phys 63 (2005) S73-S74
30. Peeters S.T., Hoogeman M.S., Heemsbergen W.D., et al. Volume and hormonal effects for acute side effects of rectum and bladder during conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 63 (2005) 1142-1152
31. Fiorino C., Dell'Oca I., Pierelli A., et al. Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy. Radiother Oncol 78 (2006) 276-282